Evidence map›Paper›PMID 41127242›Full record

SynthesisFrontiers in aging neuroscience2025

Cognitive changes preceding Parkinson's disease: a systematic review and meta-analysis of prospective population-based studies.

Noelia Peña Arauzo, Christoph Theyer, Florian Krismer, Atbin Djamshidian, Werner Poewe, Corinne Horlings, Beatrice Heim, Laura Zamarian, Philipp Mahlknecht

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Noelia Peña ArauzoDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Christoph TheyerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Florian KrismerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Atbin DjamshidianDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Werner PoeweDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Corinne HorlingsDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Beatrice HeimDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Laura Zamarian *Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Philipp Mahlknecht *Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Various non-motor symptoms have been studied as part of the prodromal phase of Parkinson's disease (PD). However, studies assessing cognitive changes are scarce. Methods: We systematically searched PubMed and SCOPUS to identify prospective, population-based studies that reported on cognitive performance in individuals without PD at baseline, the incidence of PD at follow-up, and comparisons of cognitive performance between participants who developed PD and controls. Results: Twelve studies were identified, including a total of 524,807 participants, of whom 2,939 developed PD. Four studies found differences in global cognition and a meta-analysis showed that individuals who developed PD scored 0.3 points lower than controls on the Mini-Mental State Examination at baseline. Cognitive changes were most frequently observed in tests of executive function, processing-speed and attention, and less frequently in visuospatial/visuoconstructive skills and memory. Due to the heterogeneity of the assessment methods used, it was not possible to conduct further meta-analyses. Conclusions: Cognitive changes may be part of the clinical picture in prodromal PD cohorts derived from the general population. Further population-based studies with large samples and long-term follow-up are needed to better understand their extent and significance. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024547252, identifier: CRD42024547252.

Indexed as

cognitionexecutive functionneuropsychologynon-motor symptomsprodromal

Identifiers

PMID41127242
PMCPMC12537721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.